Search results
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 3 hours agoWe aim to bring this novel treatment option to patients in need as quickly as possible.” The company...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 2 days agoThat’s when I knew it was time to see a doctor and get help. Learn More: What Is Psoriasis? My Early...
Nail Psoriasis
Health via Yahoo News· 6 days agoBiopsy: Your provider might collect a biopsy (small skin sample) from the nail bed and send it to a laboratory for evaluation. Nail Psoriasis Treatment...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 1 day agoThere, Joel M. Gelfand, MD, professor of dermatology and epidemiology at the University of Pennsylvania in Philadelphia, presented results from the LITE...
Tracking down the genetic causes of lupus to personalize treatment
Medical Xpress· 31 minutes agoResearchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies to those who will benefit most. In the latest advance ...
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena via Yahoo Finance· 6 days ago"BMS reports four-year data from psoriasis treatment extension trial" was originally created and...
Comprehensive Dermatology and Radio Frequency Treatment in Abu Dhabi
Digital Journal· 10 hours agoAbu Dhabi is a premier destination for advanced dermatological care and cutting-edge treatments. Whether you are looking for comprehensive dermatology services or the latest ...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 11 hours agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 7 hours agoTwice-daily doses of Palisade's oral prodrug PALI-2108 for eight days protected mouse models of...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 2 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...